Israel Active

Researchers at Ben Gurion University have discovered a new biological event that can control an excessive production of genes involved in cancer cell formation. Discovery of “the methylation of BRD4” advances scientific understanding of human cancer progression and its treatment.

Israeli-Arab Technion PhD graduate Hanan Abumanhal has discovered sodium bicarbonate (baking soda) increases the potency of chemotherapy. For her doctorate, she developed nano particles to reduce the acidity of tumors, allowing reduced quantities of chemo to penetrate.

The Phase 1 / 2 trial of DSP107 from Israel’s KAHR Medical (see previously) has commenced and will now be expanded to include blood cancer patients in addition to solid tumors. KAHR has received an additional investment of $5 million to fund the enlarged trial.

Israelis Dr Igal & Alon Kushnir founded RedDress Medical to develop ActiGraft - a revolutionary fast treatment that uses blood clots made from the patient’s own blood to heal chronic wounds such as diabetic foot ulcers. It is saving lives in Israel, the US and 15 other countries. (testimonial from a South African Muslim)

Technion UK’s webinar on 31st May features Israel’s Rafi Nave, senior researcher at Israel’s Technion. He headed the development of the PillCam, the world’s first ingestible camera for imaging the digestive tract. NHS UK is about to use PillCam for 11,000 patients across England.

Israel’s PatenSee has developed an image system to detect deterioration of fistulas – the artery / vein connection from dialysis machines to patients. Over time these connections fail due to blockages (stenoses), risking blood clots and thromboses. The system is in trials at two Israeli hospitals.

Israel’s CytoReason (see previously) is partnering Swiss multinational Ferring to find new treatments for patients with inflammatory bowel disease (IBD). CytoReason’s AI technology will enable the joint building of models of diseased cells on which therapies will be tested.

Researchers from The Hebrew University of Jerusalem and Penn State College of Medicine have made an important discovery about the protein alpha-synuclein, associated with the development of Parkinson’s and dementia. It gives hope for new therapeutics to delay or halt their progression.

Israel’s Ibex Medical Analytics (see previously) has received Europe’s CE Mark for its Galen Breast image analysis solution to help pathologists detect various types of cancer. It follows successful trials in Israel and France.

Israeli founded Laguna Health aims to reduce costly hospital readmissions and shorten recovery times. Its app can provide patients in the US either with a fully digital and personalized recovery journey or enable interactions with live expert recovery coaches via text, telephone or video.